Auditors ✓ Lawyers ✓ Tax advisors ✓ and business consultants ✓ : Four perspectives. One solution. Worldwide. Learn …
Auditing and audit-related advice for companies ✓ Experienced auditors ✓ Excellent advice ✓ Tailor-made solutions » …
Our clients entrust us with their most important legal matters. Learn more about our legal services!
Tax laws are complex and dynamic. We face the challenge of tax law together with you - find out more.
Business consulting for companies ✓ Experienced consultants ✓ Excellent advice ✓ Tailor-made solutions » more
In-house or outsourcing? Strategic decisions in accounting
Avoid shareholder conflicts: Structure instead of ambiguity
How far can the rights of a criminal defense insurer extend?
EU “Omnibus” Package: Less effort for sustainability reporting?
Baker Tilly starts the year 2025 with 23 new Directors
Challenges in corporate finance: Baker Tilly at Structured FINANCE 2024
Pay slips are purely information documents
Financing and funding: realignment in the coalition agreement
Accounting in corporate groups: Standardized structures instead of isolated solutions
Survey: Two thirds of German automotive suppliers anticipate a market shakeout
NIS-2 and no end in sight: implementation in Germany delayed further
Public procurement: Legally compliant procurement of cyber insurance
Cross-industry expertise for individual solutions ✓ Our interdisciplinary teams combine expertise & market …
Baker Tilly advises biotech startup Real Collagen GmbH investment by US investor
Energy study: Uncertainty slows down investments by industry and utilities in Germany
Risk management ✓ Compliance and controls ✓ Increase and ensure security & conformity ✓ more»
Baker Tilly offers a wide range of individual and innovative consulting services. Find out more!
Baker Tilly provided end-to-end transaction advisory services to natural medicines manufacturer Bionorica on its acquisition of pharmaceutical contract manufacturer Lomapharm.
Comprehensive transaction expertise for an investment in the future: Baker Tilly provided comprehensive legal, tax and business management advice to pharmaceutical manufacturer Bionorica SE on the acquisition of Lomapharm GmbH. Through the purchase of the company, which specializes in contract manufacturing in Emmerthal, Lower Saxony, Bionorica has secured further capacity for the production of its herbal medicines. The acquisition has taken effect on March 31, 2023.
The Baker Tilly team supported the transaction with comprehensive legal, tax and financial due diligence advice. In addition, the team drafted and negotiated the transaction agreements, such as the Share Purchase Agreement.
Baker Tilly’s lead partner on this transaction was the Munich-based partner Stephan Zuber, Attorney-at-Law (Corporate, M&A), together with partner Robert Rostek, Attorney-at-Law (Corporate, M&A), and a legal team including partner Dr. Christian Engelhardt, Attorney-at-Law (IP/IT, Data Protection), Marco Stahn, Attorney-at-Law (Labor Law), Gabriele Heise, Attorney-at-Law (Public Law), Daniela Konle, Attorney-at-Law (Corporate, M&A), Sonja Dechansreiter, Attorney-at-Law (Commercial), Thomas Böhm, Attorney-at-Law (Corporate, Real Estate), and Dr. Jens Füller (Antitrust). Partner Christian Wegener, Tax Advisor, was responsible for tax advice together with Christiane Krüger, Attorney-at-Law/Tax Advisor, and Pauline Paff, Tax Advisor. The two Baker Tilly partners Frank Stahl, German CPA/Tax Advisor and Stefan Greger as well as Anja Stöckle focused on financial due diligence and business management advice.
Lomapharm has 165 employees and was part of the Japanese group Daicel Corporation since October 2018. According to Bionorica, the company will continue to exist independently in the market. Bionorica, based in Neumarkt in der Oberpfalz, Germany, is a leading global manufacturer of herbal medicines. Around 2,000 employees work at 20 sites worldwide. In 2021, the company generated sales of 288 million euros. “We are delighted to welcome Lomapharm to the Bionorica family, a company that not only stands out in terms of exceptional expertise and high employee commitment, but as a traditional former family business also fits well with our corporate culture,” said Prof. Dr. Michael Popp, CEO and owner of Bionorica SE. In order to promote the independent development of Lomapharm and to make the local jobs sustainable in the long term, Bionorica has announced expansion investments at Lomapharm in the double-digit million-euro range.
Robert Rostek, LL.M. (UNSW)
Partner
Attorney-at-Law (Rechtsanwalt)
Contact now
Contact us
View all news